| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.21e-05 | 130 | 164 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 NCOA6 RBBP8 GATA6 CRTC1 TACC2 MDFI IFI16 NR1D1 CREBBP YEATS2 PARP10 NCOR2 LATS1 MTOR YAP1 ARID2 NFYA TP53BP1 | 1.42e-05 | 753 | 164 | 19 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 NCOA6 RBBP8 BCORL1 GON4L IFI16 CREBBP YEATS2 PARP10 NCOR2 ARID1B CRYM KMT2D YAP1 SQSTM1 TP53BP1 | 1.65e-05 | 562 | 164 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.19e-04 | 229 | 164 | 9 | GO:0003714 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 GPHN NCOA6 GATAD2A ANK2 RBBP8 BCORL1 GON4L ICE1 IFI16 CREBBP AXIN2 YEATS2 PARP10 NCOR2 ARID1B CRYM KMT2D AP2A1 ZMYND10 YAP1 SQSTM1 RPA1 TP53BP1 | 3.00e-04 | 1356 | 164 | 24 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin-protein adaptor activity | 3.51e-04 | 41 | 164 | 4 | GO:0140463 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | PDXDC1 COL5A1 TES ADAM9 PKP4 EPS8L1 AHSA1 ITGB4 TENM2 PTPRF AHNAK PVR CDH2 NOS2 | 4.37e-04 | 599 | 164 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 NCOA6 GATAD2A ANK2 RBBP8 BCORL1 GON4L ICE1 IFI16 CREBBP YEATS2 PARP10 NCOR2 ARID1B CRYM KMT2D AP2A1 YAP1 SQSTM1 RPA1 TP53BP1 | 5.51e-04 | 1160 | 164 | 21 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 5.60e-04 | 20 | 164 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | serotonin-gated monoatomic cation channel activity | 6.60e-04 | 5 | 164 | 2 | GO:0022850 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 8.54e-04 | 23 | 164 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | serotonin receptor activity | 9.84e-04 | 6 | 164 | 2 | GO:0099589 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA2 NCOA6 RBBP8 GATA6 CRTC1 TACC2 MDFI CREBBP PARP10 NCOR2 LATS1 YAP1 TP53BP1 | 1.06e-03 | 582 | 164 | 13 | GO:0140297 |
| GeneOntologyCellularComponent | nuclear body | NCOA2 GATAD2A INCENP GON4L CRTC1 ICE1 IFI16 NR1D1 CREBBP TENM2 PRPF40A PHC1 ZWINT NCOR2 BPHL MTOR SQSTM1 GLI2 RBM15B RPA1 PSPC1 TP53BP1 | 2.64e-06 | 903 | 165 | 22 | GO:0016604 |
| GeneOntologyCellularComponent | U2-type prespliceosome | 3.61e-04 | 18 | 165 | 3 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 3.61e-04 | 18 | 165 | 3 | GO:0071010 | |
| GeneOntologyCellularComponent | collagen type V trimer | 3.68e-04 | 4 | 165 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | GLI-SUFU complex | 3.68e-04 | 4 | 165 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | T-tubule | 4.06e-04 | 79 | 165 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.79e-04 | 21 | 165 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | serotonin-activated cation-selective channel complex | 6.10e-04 | 5 | 165 | 2 | GO:1904602 | |
| GeneOntologyCellularComponent | serotonin receptor complex | 6.10e-04 | 5 | 165 | 2 | GO:0098665 | |
| GeneOntologyCellularComponent | cell cortex | COL10A1 FRMPD1 CLASP2 ITGB4 KIAA1614 SHROOM1 EXOC3L4 CDH2 NOS2 EPB41L2 | 7.53e-04 | 371 | 165 | 10 | GO:0005938 |
| GeneOntologyCellularComponent | condensed chromosome | 7.67e-04 | 307 | 165 | 9 | GO:0000793 | |
| GeneOntologyCellularComponent | cell-cell contact zone | 8.99e-04 | 94 | 165 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | desmosome | 1.37e-03 | 28 | 165 | 3 | GO:0030057 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.46e-03 | 405 | 165 | 10 | GO:0045211 | |
| Domain | Alpha_tubulin | 2.96e-11 | 9 | 160 | 6 | IPR002452 | |
| Domain | - | 1.26e-08 | 20 | 160 | 6 | 3.30.1330.20 | |
| Domain | - | 1.76e-08 | 21 | 160 | 6 | 1.10.287.600 | |
| Domain | Tubulin_C | 2.40e-08 | 22 | 160 | 6 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 2.40e-08 | 22 | 160 | 6 | IPR018316 | |
| Domain | - | 2.40e-08 | 22 | 160 | 6 | 3.40.50.1440 | |
| Domain | Tubulin_C | 2.40e-08 | 22 | 160 | 6 | SM00865 | |
| Domain | Tub_FtsZ_C | 3.22e-08 | 23 | 160 | 6 | IPR008280 | |
| Domain | Tubulin_C | 3.22e-08 | 23 | 160 | 6 | IPR023123 | |
| Domain | TUBULIN | 3.22e-08 | 23 | 160 | 6 | PS00227 | |
| Domain | Tubulin | 3.22e-08 | 23 | 160 | 6 | IPR000217 | |
| Domain | Tubulin | 3.22e-08 | 23 | 160 | 6 | SM00864 | |
| Domain | Tubulin_CS | 3.22e-08 | 23 | 160 | 6 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 4.26e-08 | 24 | 160 | 6 | IPR003008 | |
| Domain | Tubulin | 4.26e-08 | 24 | 160 | 6 | PF00091 | |
| Domain | FERM_M | 4.47e-05 | 46 | 160 | 5 | PF00373 | |
| Domain | - | 6.10e-05 | 49 | 160 | 5 | 1.20.80.10 | |
| Domain | FERM_central | 6.10e-05 | 49 | 160 | 5 | IPR019748 | |
| Domain | FERM_domain | 6.10e-05 | 49 | 160 | 5 | IPR000299 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 6.73e-05 | 50 | 160 | 5 | IPR014352 | |
| Domain | FERM_1 | 6.73e-05 | 50 | 160 | 5 | PS00660 | |
| Domain | FERM_2 | 6.73e-05 | 50 | 160 | 5 | PS00661 | |
| Domain | FERM_3 | 6.73e-05 | 50 | 160 | 5 | PS50057 | |
| Domain | Band_41_domain | 6.73e-05 | 50 | 160 | 5 | IPR019749 | |
| Domain | B41 | 6.73e-05 | 50 | 160 | 5 | SM00295 | |
| Domain | Actin-binding_Xin_repeat | 7.29e-05 | 2 | 160 | 2 | IPR012510 | |
| Domain | snRNP-assoc_SmB/SmN | 7.29e-05 | 2 | 160 | 2 | IPR017131 | |
| Domain | XIRP1/XIRP2 | 7.29e-05 | 2 | 160 | 2 | IPR030072 | |
| Domain | XIN | 7.29e-05 | 2 | 160 | 2 | PS51389 | |
| Domain | Xin | 7.29e-05 | 2 | 160 | 2 | PF08043 | |
| Domain | - | 4.33e-04 | 4 | 160 | 2 | 3.90.1460.10 | |
| Domain | SPOC | 4.33e-04 | 4 | 160 | 2 | PS50917 | |
| Domain | GTF2I | 4.33e-04 | 4 | 160 | 2 | PS51139 | |
| Domain | GTF2I | 4.33e-04 | 4 | 160 | 2 | PF02946 | |
| Domain | GTF2I | 4.33e-04 | 4 | 160 | 2 | IPR004212 | |
| Domain | UBA | 5.39e-04 | 44 | 160 | 4 | IPR015940 | |
| Domain | UBA | 6.95e-04 | 47 | 160 | 4 | PS50030 | |
| Domain | CRAL_TRIO | 7.33e-04 | 21 | 160 | 3 | PF00650 | |
| Domain | - | 9.63e-04 | 23 | 160 | 3 | 3.40.525.10 | |
| Domain | Nuc_rcpt_coact | 1.07e-03 | 6 | 160 | 2 | IPR009110 | |
| Domain | SPOC_C | 1.07e-03 | 6 | 160 | 2 | IPR012921 | |
| Domain | CPSASE_2 | 1.07e-03 | 6 | 160 | 2 | PS00867 | |
| Domain | SPOC | 1.07e-03 | 6 | 160 | 2 | PF07744 | |
| Domain | SEC14 | 1.24e-03 | 25 | 160 | 3 | SM00516 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 1.49e-03 | 7 | 160 | 2 | IPR005479 | |
| Domain | BC-like_N | 1.49e-03 | 7 | 160 | 2 | IPR005481 | |
| Domain | CPSase_L_D2 | 1.49e-03 | 7 | 160 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 1.49e-03 | 7 | 160 | 2 | PF00289 | |
| Domain | Znf_NHR/GATA | 1.54e-03 | 58 | 160 | 4 | IPR013088 | |
| Domain | CRAL_TRIO | 1.55e-03 | 27 | 160 | 3 | PS50191 | |
| Domain | CRAL-TRIO_dom | 1.73e-03 | 28 | 160 | 3 | IPR001251 | |
| Domain | Calx_beta | 1.97e-03 | 8 | 160 | 2 | SM00237 | |
| Domain | UBA | 2.11e-03 | 30 | 160 | 3 | SM00165 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.13e-11 | 22 | 129 | 8 | M47903 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 8.22e-11 | 17 | 129 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.33e-10 | 18 | 129 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.10e-10 | 19 | 129 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.10e-10 | 19 | 129 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 3.20e-10 | 20 | 129 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 3.20e-10 | 20 | 129 | 7 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 4.77e-10 | 21 | 129 | 7 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 4.77e-10 | 21 | 129 | 7 | M47767 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 9.90e-10 | 23 | 129 | 7 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 9.90e-10 | 23 | 129 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 9.90e-10 | 23 | 129 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.39e-09 | 24 | 129 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.39e-09 | 24 | 129 | 7 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.91e-09 | 25 | 129 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.91e-09 | 25 | 129 | 7 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 2.60e-09 | 26 | 129 | 7 | M9648 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.60e-09 | 26 | 129 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 4.60e-09 | 28 | 129 | 7 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 6.02e-09 | 29 | 129 | 7 | M27948 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.27e-08 | 32 | 129 | 7 | M27491 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.27e-08 | 32 | 129 | 7 | M29848 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.30e-08 | 49 | 129 | 8 | M891 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.60e-08 | 33 | 129 | 7 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.60e-08 | 33 | 129 | 7 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.48e-08 | 35 | 129 | 7 | M47774 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.55e-08 | 38 | 129 | 7 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.12e-07 | 43 | 129 | 7 | M47773 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.12e-07 | 43 | 129 | 7 | M47669 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.32e-07 | 44 | 129 | 7 | M27934 | |
| Pathway | REACTOME_AGGREPHAGY | 1.32e-07 | 44 | 129 | 7 | M29830 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.55e-07 | 45 | 129 | 7 | M47670 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | ANK2 TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B AP2A1 TUBA1A NCAN | 1.55e-07 | 121 | 129 | 10 | M872 |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.81e-07 | 46 | 129 | 7 | M27828 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | TUBA3D TUBA1C HTR3E TUBA3E SLITRK3 SYT2 TUBA4A TUBA3C TUBA1B PTPRF AP2A1 TUBA1A KCNF1 PTPRS KCNH2 HTR3D EPB41L2 | 2.03e-07 | 411 | 129 | 17 | M735 |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | INCENP TUBA3D TUBA1C TUBA3E CLASP2 TUBA4A TUBA3C ZWINT TUBA1B TUBA1A | 2.45e-07 | 127 | 129 | 10 | M27181 |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 2.90e-07 | 72 | 129 | 8 | M26954 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.36e-07 | 17 | 129 | 5 | MM14731 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 3.78e-07 | 51 | 129 | 7 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.96e-07 | 53 | 129 | 7 | M27651 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | INCENP TUBA3D TUBA1C TUBA3E CLASP2 TUBA4A TUBA3C ZWINT TUBA1B TUBA1A | 6.08e-07 | 140 | 129 | 10 | M27550 |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.43e-07 | 55 | 129 | 7 | M39613 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 7.29e-07 | 56 | 129 | 7 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 8.25e-07 | 57 | 129 | 7 | M27251 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 9.63e-07 | 37 | 129 | 6 | MM15102 | |
| Pathway | REACTOME_KINESINS | 1.32e-06 | 61 | 129 | 7 | M977 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.63e-06 | 90 | 129 | 8 | M29841 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 3.73e-06 | 71 | 129 | 7 | M39690 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 4.08e-06 | 27 | 129 | 5 | MM15674 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 4.08e-06 | 27 | 129 | 5 | MM15549 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 4.22e-06 | 102 | 129 | 8 | M27648 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 5.91e-06 | 76 | 129 | 7 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 5.91e-06 | 76 | 129 | 7 | M27215 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 5.91e-06 | 29 | 129 | 5 | MM15219 | |
| Pathway | REACTOME_ADIPOGENESIS | 7.41e-06 | 110 | 129 | 8 | M48259 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 7.65e-06 | 79 | 129 | 7 | M27743 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 9.05e-06 | 113 | 129 | 8 | M27471 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 9.42e-06 | 54 | 129 | 6 | M27482 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 9.80e-06 | 32 | 129 | 5 | MM14730 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | INCENP TUBA3D TUBA1C TUBA3E CLASP2 TUBA4A TUBA3C ZWINT TUBA1B TUBA1A | 1.00e-05 | 191 | 129 | 10 | M29614 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | NCOA2 COL5A1 NCOA6 GATAD2A ANK2 TUBA3D ZNF423 PKP4 TUBA1C GATA6 TUBA3E CLASP2 ADGRV1 ZNF467 ARHGEF11 ITGB4 CREBBP TUBA4A TUBA3C SLC2A4 FARP2 TUBA1B NCOR2 ARID1B KMT2D AP2A1 TUBA1A YAP1 NCAN CDH2 | 1.11e-05 | 1432 | 129 | 30 | M509 |
| Pathway | REACTOME_AUTOPHAGY | TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B TUBA1A MTOR SQSTM1 | 1.45e-05 | 158 | 129 | 9 | M27935 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | INCENP TUBA3D TUBA1C TUBA3E CLASP2 TUBA4A TUBA3C ZWINT TUBA1B TUBA1A | 1.78e-05 | 204 | 129 | 10 | M4217 |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | NCOA2 NCOA6 TUBA3D TUBA1C TUBA3E CRTC1 NR1D1 CREBBP TUBA4A TUBA3C TUBA1B TUBA1A | 1.78e-05 | 297 | 129 | 12 | M27050 |
| Pathway | REACTOME_AGGREPHAGY | 1.78e-05 | 36 | 129 | 5 | MM15669 | |
| Pathway | KEGG_GAP_JUNCTION | 1.82e-05 | 90 | 129 | 7 | M4013 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | TUBA3D TUBA1C HTR3E TUBA3E TUBA4A TUBA3C TUBA1B AP2A1 TUBA1A HTR3D | 1.86e-05 | 205 | 129 | 10 | M752 |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 2.01e-05 | 126 | 129 | 8 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.39e-05 | 129 | 129 | 8 | MM14894 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.41e-05 | 94 | 129 | 7 | M2843 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 2.59e-05 | 95 | 129 | 7 | M6729 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 2.89e-05 | 20 | 129 | 4 | MM1383 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 3.16e-05 | 98 | 129 | 7 | M776 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.59e-05 | 68 | 129 | 6 | MM14968 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.61e-05 | 100 | 129 | 7 | M27650 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 3.88e-05 | 138 | 129 | 8 | M29805 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 4.52e-05 | 141 | 129 | 8 | MM15266 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.84e-05 | 44 | 129 | 5 | MM14606 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 4.94e-05 | 105 | 129 | 7 | MM15206 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 5.39e-05 | 73 | 129 | 6 | MM15672 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | INCENP TUBA3D TUBA1C TUBA3E CLASP2 TUBA4A TUBA3C ZWINT TUBA1B TUBA1A | 6.17e-05 | 236 | 129 | 10 | M27185 |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 7.01e-05 | 150 | 129 | 8 | M27440 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL5A1 ANK2 TUBA3D TUBA1C TUBA3E CLASP2 ADGRV1 ARHGEF11 TUBA4A TUBA3C FARP2 TUBA1B AP2A1 TUBA1A YAP1 NCAN | 7.07e-05 | 575 | 129 | 16 | M29853 |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.42e-05 | 48 | 129 | 5 | MM15353 | |
| Pathway | REACTOME_HEME_SIGNALING | 8.20e-05 | 49 | 129 | 5 | M41832 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 9.24e-05 | 156 | 129 | 8 | M27097 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.09e-04 | 52 | 129 | 5 | MM15211 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.09e-04 | 52 | 129 | 5 | MM14949 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.18e-04 | 84 | 129 | 6 | M1008 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.20e-04 | 162 | 129 | 8 | M29804 | |
| Pathway | WP_ALZHEIMERS_DISEASE | TUBA3D TUBA1C TUBA3E TUBA4A TUBA3C AXIN2 TUBA1B TUBA1A MTOR NOS2 | 1.42e-04 | 261 | 129 | 10 | M42565 |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.43e-04 | 55 | 129 | 5 | M27145 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.68e-04 | 170 | 129 | 8 | M941 | |
| Pathway | REACTOME_KINESINS | 1.70e-04 | 57 | 129 | 5 | MM15714 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | NCOA2 INCENP TUBA3D TUBA1C TUBA3E CLASP2 TUBA4A TUBA3C ZWINT TUBA1B TUBA1A | 1.85e-04 | 323 | 129 | 11 | M27080 |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | NCOA2 NCOA6 NOX5 TUBA3D TUBA1C TUBA3E CRTC1 NR1D1 CREBBP TUBA4A TUBA3C PHC1 TUBA1B NCOR2 TUBA1A MTOR SQSTM1 NFYA RPA1 | 1.86e-04 | 828 | 129 | 19 | M27827 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | TUBA3D TUBA1C HTR3E TUBA3E TUBA4A TUBA3C TUBA1B AP2A1 TUBA1A HTR3D | 1.87e-04 | 270 | 129 | 10 | M15514 |
| Pathway | REACTOME_MACROAUTOPHAGY | 1.90e-04 | 130 | 129 | 7 | MM14627 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 2.29e-04 | 134 | 129 | 7 | M27751 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 2.62e-04 | 137 | 129 | 7 | MM15182 | |
| Pubmed | 1.85e-15 | 9 | 167 | 7 | 21167302 | ||
| Pubmed | 2.49e-12 | 19 | 167 | 7 | 15698476 | ||
| Pubmed | 2.49e-12 | 19 | 167 | 7 | 15691386 | ||
| Pubmed | 8.32e-12 | 22 | 167 | 7 | 28117675 | ||
| Pubmed | 1.44e-11 | 6 | 167 | 5 | 3785200 | ||
| Pubmed | 3.26e-11 | 14 | 167 | 6 | 12482968 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 1.33e-10 | 8 | 167 | 5 | 16148047 | |
| Pubmed | 5.13e-10 | 4 | 167 | 4 | 18400243 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NCOA2 GATAD2A TUBA1C TACC2 MCCC1 CPS1 IFI16 AHSA1 CREBBP PRPF40A TUBA3C YEATS2 NCOR2 AHNAK RPA1 EPB41L2 | 5.46e-10 | 444 | 167 | 16 | 34795231 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 FRMD8 TBC1D25 CLASP2 ICE1 MDFI ZNF236 ARHGEF11 ADGRA2 GBA2 ITGB4 NHSL1 NCOR2 KMT2D PTPRF AP2A1 PTPRS MTOR PLEKHO2 KCNH2 GLI1 AHNAK PCNX1 MBD5 | 7.29e-10 | 1105 | 167 | 24 | 35748872 |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 7.84e-10 | 22 | 167 | 6 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.85e-09 | 12 | 167 | 5 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 3.00e-09 | 13 | 167 | 5 | 10908577 | |
| Pubmed | 4.65e-09 | 14 | 167 | 5 | 12486001 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 GATAD2A INCENP TUBA1C BCORL1 ICE1 MCCC1 PRPF40A TUBA4A TUBA1B YEATS2 NCOR2 ARID1B ARID2 AHNAK RBM15B RPRD2 SNRPB PSPC1 SNRPN TP53BP1 | 7.35e-09 | 954 | 167 | 21 | 36373674 |
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 7.63e-09 | 6 | 167 | 4 | 7651436 | |
| Pubmed | 7.63e-09 | 6 | 167 | 4 | 16327313 | ||
| Pubmed | 1.42e-08 | 17 | 167 | 5 | 17360745 | ||
| Pubmed | 1.77e-08 | 7 | 167 | 4 | 36681692 | ||
| Pubmed | 1.77e-08 | 7 | 167 | 4 | 11146551 | ||
| Pubmed | NCOA2 GPHN ANK2 ADAM9 PKP4 CLASP2 ARHGEF11 TENM2 WDR91 NCOR2 AP2A1 PTPRS MTOR NCAN PPP1R3F PRKCE RPA1 CDH2 EPB41L2 TP53BP1 | 4.46e-08 | 963 | 167 | 20 | 28671696 | |
| Pubmed | 5.93e-08 | 22 | 167 | 5 | 15103018 | ||
| Pubmed | 6.34e-08 | 9 | 167 | 4 | 19103752 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 6.34e-08 | 9 | 167 | 4 | 11953448 | |
| Pubmed | NCOA2 GPHN NCOA6 TES CREBBP PRPF40A YEATS2 ARID1B KMT2D LATS1 YAP1 ARID2 AHNAK RPRD2 TP53BP1 | 7.57e-08 | 549 | 167 | 15 | 38280479 | |
| Pubmed | NCOA2 COL5A1 ANK2 ZNF423 FAT3 MTSS1 GATA6 BAX GON4L TACC2 CPS1 RSC1A1 PHC1 NCOR2 NSUN5 GTF2IRD2B SEC14L6 PTPRS ARID2 NCAN KLHL8 CDH2 | 9.93e-08 | 1215 | 167 | 22 | 15146197 | |
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 11163133 | ||
| Pubmed | 1.09e-07 | 3 | 167 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 1.09e-07 | 3 | 167 | 3 | 9722999 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | GATAD2A ZNF423 TUBA1C GATA6 CPS1 PRPF40A PHC1 WDR91 TUBA1B YEATS2 NCOR2 AP2A1 PSPC1 | 1.10e-07 | 411 | 167 | 13 | 35182466 |
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 1.65e-07 | 11 | 167 | 4 | 20405035 | |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 1.72e-07 | 84 | 167 | 7 | 25670202 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 NCOA6 UBQLN1 APOBR NCOR2 LATS1 XIRP2 YAP1 SQSTM1 MAP4K1 GLI2 ARID2 TMEM139 | 1.84e-07 | 430 | 167 | 13 | 35044719 |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.36e-07 | 130 | 167 | 8 | 35545047 | |
| Pubmed | NCOA2 NCOA6 GATAD2A BCORL1 GATA6 GON4L R3HDM2 MCCC1 CREBBP PRPF40A YEATS2 NCOR2 ARID1B KMT2D YAP1 SQSTM1 GLI2 ARID2 NFYA RPRD2 RPA1 SMAP2 TP53BP1 | 3.97e-07 | 1429 | 167 | 23 | 35140242 | |
| Pubmed | UBQLN1 TUBA1C PKD1L2 GBA2 ITGB4 TUBA4A TUBA1B CRYM TUBA1A RPRD2 HDAC10 | 5.06e-07 | 322 | 167 | 11 | 26514267 | |
| Pubmed | 5.12e-07 | 33 | 167 | 5 | 19336002 | ||
| Pubmed | GPHN TES UBQLN1 TUBA1C AHSA1 PRPF40A NCOR2 AHNAK RPRD2 PSPC1 EPB41L2 TP53BP1 | 5.86e-07 | 399 | 167 | 12 | 35987950 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | ANK2 TUBA1C TUBA4A TUBA3C TUBA1B TUBA1A AHNAK RPRD2 PSPC1 TP53BP1 | 8.44e-07 | 271 | 167 | 10 | 32433965 |
| Pubmed | TUBA3D TUBA1C TUBA3E IFI16 TUBA4A TUBA3C TUBA1B TUBA1A SNRPB | 9.54e-07 | 212 | 167 | 9 | 23463506 | |
| Pubmed | 9.94e-07 | 157 | 167 | 8 | 30186101 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOA2 RBBP8 BCORL1 TACC2 MCCC1 CREBBP ZWINT YEATS2 NCOR2 TUBA1A YAP1 SQSTM1 ARID2 TP53BP1 | 1.08e-06 | 588 | 167 | 14 | 38580884 |
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 12810069 | ||
| Pubmed | 1.08e-06 | 5 | 167 | 3 | 12203715 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.17e-06 | 281 | 167 | 10 | 28706196 | |
| Pubmed | DZIP1L TUBA1C ICE1 TUBA4A TUBA1B TUBA1A SQSTM1 AHNAK SNRPB SNRPN | 1.29e-06 | 284 | 167 | 10 | 29459677 | |
| Pubmed | 1.49e-06 | 18 | 167 | 4 | 12639940 | ||
| Pubmed | NCOA2 NCOA6 UBQLN1 GATAD2A BCORL1 IKZF1 IFI16 AHSA1 CREBBP YEATS2 NCOR2 NSUN5 ARID1B KMT2D DIMT1 ARID2 RPA1 PSPC1 TP53BP1 | 1.65e-06 | 1103 | 167 | 19 | 34189442 | |
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 18613978 | ||
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 12090300 | ||
| Pubmed | 2.15e-06 | 6 | 167 | 3 | 20503377 | ||
| Pubmed | 2.34e-06 | 20 | 167 | 4 | 11877444 | ||
| Pubmed | 2.34e-06 | 20 | 167 | 4 | 19668339 | ||
| Pubmed | Identification of Protor as a novel Rictor-binding component of mTOR complex-2. | 2.34e-06 | 20 | 167 | 4 | 17461779 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ATP8B3 TES PKP4 WDR46 TBC1D25 ZNF236 ITGB4 ZWINT WDR91 TUBA1B GTF2IRD2B BPHL YAP1 AHNAK ZNF79 SPOCD1 EPB41L2 | 2.56e-06 | 925 | 167 | 17 | 28986522 |
| Pubmed | 2.88e-06 | 21 | 167 | 4 | 19596656 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 PRUNE2 COL5A1 FRMPD1 SLITRK3 CLASP2 SYT2 ADGRV1 ZNF236 CREBBP FARP2 PLEKHH1 YEATS2 PARP10 NCOR2 PTPRS GLI2 PVR PRKCE RPRD2 CSMD1 MBD5 | 2.94e-06 | 1489 | 167 | 22 | 28611215 |
| Pubmed | TUBA1C BCORL1 ZNF467 PHC1 YEATS2 NCOR2 NSUN5 ARID1B TUBA1A SNRPB TP53BP1 | 3.75e-06 | 396 | 167 | 11 | 26687479 | |
| Pubmed | Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis. | 3.75e-06 | 7 | 167 | 3 | 30154246 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA2 GATAD2A BCORL1 GON4L CREBBP YEATS2 NCOR2 ARID1B KMT2D ARID2 RPA1 | 3.93e-06 | 398 | 167 | 11 | 35016035 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN NCOA6 TRPM7 CRTC1 CLASP2 MCCC1 NHSL1 LATS1 MTOR YAP1 SQSTM1 MAP4K1 AHNAK PRKCE SMAP2 EPB41L2 | 4.47e-06 | 861 | 167 | 16 | 36931259 |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 4.49e-06 | 256 | 167 | 9 | 24189400 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 RBBP8 IFI16 NR1D1 PRPF40A YEATS2 NCOR2 NSUN5 KMT2D LATS1 YAP1 MAP4K1 RBM15B EPB41L2 TP53BP1 | 5.47e-06 | 774 | 167 | 15 | 15302935 |
| Pubmed | 5.98e-06 | 8 | 167 | 3 | 11959865 | ||
| Pubmed | Wnt signaling determines ventral spinal cord cell fates in a time-dependent manner. | 6.00e-06 | 25 | 167 | 4 | 18927156 | |
| Pubmed | RBBP8 BCORL1 CRTC1 ICE1 MCCC1 PHC1 YEATS2 NCOR2 KMT2D SQSTM1 AHNAK | 6.26e-06 | 418 | 167 | 11 | 34709266 | |
| Pubmed | Acentriolar mitosis activates a p53-dependent apoptosis pathway in the mouse embryo. | 8.26e-06 | 27 | 167 | 4 | 24706806 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 NCOA6 ZNF423 BCORL1 CREBBP NCOR2 ARID1B KMT2D ARID2 CDH2 | 8.40e-06 | 351 | 167 | 10 | 38297188 |
| Pubmed | 8.94e-06 | 9 | 167 | 3 | 23423383 | ||
| Pubmed | Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway. | 8.94e-06 | 9 | 167 | 3 | 28169360 | |
| Pubmed | 9.35e-06 | 152 | 167 | 7 | 38360978 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TES GATAD2A INCENP PKP4 TUBA1C IFI16 AHSA1 ITGB4 TUBA4A TUBA1B NSUN5 DIMT1 AP2A1 SQSTM1 AHNAK RBM15B SNRPB PSPC1 EPB41L2 | 1.07e-05 | 1257 | 167 | 19 | 36526897 |
| Pubmed | 1.11e-05 | 29 | 167 | 4 | 27320915 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 1.15e-05 | 288 | 167 | 9 | 31501420 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.21e-05 | 220 | 167 | 8 | 35785414 | |
| Pubmed | 1.27e-05 | 10 | 167 | 3 | 16284117 | ||
| Pubmed | RBBP8 ICE1 IFI16 CREBBP TUBA4A PHC1 ARID1B RPRD2 RPA1 PSPC1 TP53BP1 | 1.33e-05 | 453 | 167 | 11 | 29656893 | |
| Pubmed | 1.74e-05 | 11 | 167 | 3 | 36125128 | ||
| Pubmed | 1.74e-05 | 11 | 167 | 3 | 22493482 | ||
| Pubmed | Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. | 1.74e-05 | 11 | 167 | 3 | 29849151 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 1.83e-05 | 67 | 167 | 5 | 21875946 | |
| Pubmed | PAR3 restricts the expansion of neural precursor cells by regulating hedgehog signaling. | 1.88e-05 | 33 | 167 | 4 | 36218069 | |
| Pubmed | PDXDC1 GPHN NCOA6 GATAD2A INCENP YEATS2 ARID1B ARID2 RPRD2 PSPC1 TP53BP1 | 1.94e-05 | 472 | 167 | 11 | 38943005 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | UBQLN1 GATAD2A TUBA1C GON4L ARID2 AHNAK RPA1 SNRPN EPB41L2 TP53BP1 | 2.27e-05 | 394 | 167 | 10 | 27248496 |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 33125874 | ||
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 15025939 | ||
| Pubmed | Maintenance of Taste Organs Is Strictly Dependent on Epithelial Hedgehog/GLI Signaling. | 2.29e-05 | 2 | 167 | 2 | 27893742 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 34343821 | ||
| Pubmed | PKCε regulates contraction-stimulated GLUT4 traffic in skeletal muscle cells. | 2.29e-05 | 2 | 167 | 2 | 20658540 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 32575385 | ||
| Pubmed | Emergence of Xin demarcates a key innovation in heart evolution. | 2.29e-05 | 2 | 167 | 2 | 18682726 | |
| Pubmed | Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. | 2.29e-05 | 2 | 167 | 2 | 25288394 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 29780826 | ||
| Pubmed | YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression. | 2.29e-05 | 2 | 167 | 2 | 38308096 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 2.29e-05 | 2 | 167 | 2 | 24268707 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 8510173 | ||
| Pubmed | Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes. | 2.29e-05 | 2 | 167 | 2 | 30695055 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 8595911 | ||
| Pubmed | Gli1 interacts with YAP1 to promote tumorigenesis in esophageal squamous cell carcinoma. | 2.29e-05 | 2 | 167 | 2 | 31957872 | |
| Pubmed | 2.29e-05 | 2 | 167 | 2 | 21949121 | ||
| Interaction | SMG7 interactions | NCOA2 NCOA6 PLEKHA4 R3HDM2 SYT2 CREBBP YEATS2 NCOR2 ARID1B KMT2D LATS1 AP2A1 SQSTM1 RPRD2 RPA1 SMAP2 | 7.94e-09 | 319 | 164 | 16 | int:SMG7 |
| Interaction | TCP11L2 interactions | 1.30e-08 | 21 | 164 | 6 | int:TCP11L2 | |
| Interaction | SETD1A interactions | NCOA6 PLEKHA4 SYT2 CREBBP YEATS2 KMT2D YAP1 AHNAK RPA1 EPB41L2 TP53BP1 | 1.50e-07 | 170 | 164 | 11 | int:SETD1A |
| Interaction | GATA4 interactions | GATAD2A ZNF423 TUBA1C GATA6 MCCC1 CPS1 PRPF40A PHC1 WDR91 TUBA1B YEATS2 NCOR2 AP2A1 SQSTM1 RPA1 PSPC1 | 2.63e-07 | 411 | 164 | 16 | int:GATA4 |
| Interaction | CCT2 interactions | ANK2 TUBA1C WDR46 PLEKHA4 TUBA3E AHSA1 PRPF40A TUBA4A TUBA3C WDR91 TUBA1B TUBA1A YAP1 SQSTM1 GLI1 MAP4K1 KLHL8 RPA1 SMAP2 NOS2 | 5.15e-07 | 666 | 164 | 20 | int:CCT2 |
| Interaction | TOP3B interactions | NCOA6 PLEKHA4 FRMD8 TBC1D25 R3HDM2 CLASP2 ICE1 MDFI ZNF236 ARHGEF11 ADGRA2 GBA2 ITGB4 AXIN2 NHSL1 NCOR2 KMT2D PTPRF AP2A1 PTPRS MTOR PLEKHO2 KCNH2 GLI1 AHNAK PCNX1 MBD5 SNRPB RPA1 SMAP2 TP53BP1 | 8.29e-07 | 1470 | 164 | 31 | int:TOP3B |
| Interaction | EGR2 interactions | NCOA2 NCOA6 BCORL1 CREBBP NCOR2 ARID1B KMT2D ARID2 RBM15B CDH2 | 1.42e-06 | 171 | 164 | 10 | int:EGR2 |
| Interaction | PSMC3 interactions | UBQLN1 MTSS1 PLEKHA4 BAX IFI16 YEATS2 LATS1 YAP1 SQSTM1 GLI2 FAM83D RPA1 NOS2 TP53BP1 CCDC40 | 2.14e-06 | 425 | 164 | 15 | int:PSMC3 |
| Interaction | PPP1R10 interactions | PLEKHA4 PRPF40A CAPN13 YAP1 RBM15B SNRPB RPA1 PSPC1 EPB41L2 TP53BP1 | 2.14e-06 | 179 | 164 | 10 | int:PPP1R10 |
| Interaction | CCT3 interactions | TUBA1C WDR46 PLEKHA4 TUBA3E AHSA1 ADGRA2 TUBA4A TUBA3C TUBA1B TUBA1A YAP1 SQSTM1 MAP4K1 KLHL8 RPA1 SMAP2 NOS2 EPB41L2 | 2.22e-06 | 604 | 164 | 18 | int:CCT3 |
| Interaction | RBM25 interactions | GATAD2A PLEKHA4 IKZF1 SYT2 IFI16 PRPF40A ZWINT YAP1 TSPYL5 SNRPB RPA1 PSPC1 EPB41L2 | 2.53e-06 | 323 | 164 | 13 | int:RBM25 |
| Interaction | NCOA6 interactions | 2.96e-06 | 145 | 164 | 9 | int:NCOA6 | |
| Interaction | TUBA1B interactions | TES TUBA1C TUBA3E TACC2 IFI16 PRPF40A TUBA4A TUBA1B PTPRF TUBA1A MTOR YAP1 SQSTM1 GLI1 TSPYL5 PRKCE | 3.25e-06 | 498 | 164 | 16 | int:TUBA1B |
| Interaction | TUBB4B interactions | TES TUBA3D TUBA1C IKZF1 CLASP2 TACC2 TUBA4A TUBA3C TUBA1B PTPRF TUBA1A YAP1 SQSTM1 FAM83D PRKCE RPA1 EPB41L2 | 3.38e-06 | 560 | 164 | 17 | int:TUBB4B |
| Interaction | SUMO1 interactions | NCOA2 WDR46 PLEKHA4 IFI16 CREBBP PHC1 NCOR2 MTOR YAP1 GLI2 RPA1 TP53BP1 | 4.23e-06 | 287 | 164 | 12 | int:SUMO1 |
| Interaction | SOX7 interactions | 4.73e-06 | 82 | 164 | 7 | int:SOX7 | |
| Interaction | CCT7 interactions | TES TUBA1C WDR46 PLEKHA4 TUBA3E ICE1 PRPF40A TUBA4A TUBA1B TUBA1A SQSTM1 MAP4K1 KLHL8 MBD5 RPA1 SMAP2 NOS2 | 4.80e-06 | 575 | 164 | 17 | int:CCT7 |
| Interaction | H2BC3 interactions | UBQLN1 GATAD2A TUBA1C GON4L CREBBP KMT2D USP38 YAP1 ARID2 AHNAK TSPYL5 RPA1 SNRPN TP53BP1 | 6.19e-06 | 406 | 164 | 14 | int:H2BC3 |
| Interaction | CCT5 interactions | TUBA1C PLEKHA4 IFI16 TUBA4A TUBA1B TUBA1A YAP1 SQSTM1 MAP4K1 AHNAK KLHL8 MBD5 RPA1 SMAP2 NOS2 EPB41L2 | 6.34e-06 | 525 | 164 | 16 | int:CCT5 |
| Interaction | SMC5 interactions | NCOA6 GATAD2A INCENP TUBA1C BCORL1 PLEKHA4 ICE1 MCCC1 PRPF40A TUBA4A TUBA1B YEATS2 NCOR2 ARID1B ARID2 AHNAK RBM15B RPRD2 SNRPB RPA1 PSPC1 SNRPN TP53BP1 | 6.55e-06 | 1000 | 164 | 23 | int:SMC5 |
| Interaction | XRCC6 interactions | NCOA6 GATAD2A RBBP8 PLEKHA4 BAX IKZF1 ICE1 IFI16 AHSA1 CREBBP PRPF40A TUBA1B DIMT1 TUBA1A YAP1 NFYA RPRD2 MBD5 RPA1 PSPC1 SNRPN TP53BP1 | 6.60e-06 | 928 | 164 | 22 | int:XRCC6 |
| Interaction | CREBBP interactions | NCOA2 NCOA6 GATAD2A CRTC1 CLASP2 TACC2 CREBBP NCOR2 ARID1B KMT2D LATS1 PTPRF YAP1 NFYA HDAC10 CDH2 TP53BP1 | 8.21e-06 | 599 | 164 | 17 | int:CREBBP |
| Interaction | TUBA1C interactions | TES TUBA1C PLEKHA4 CPS1 TUBA4A TUBA3C PHC1 TUBA1B TUBA1A YAP1 SQSTM1 AHNAK PRKCE RPA1 EPB41L2 | 8.85e-06 | 478 | 164 | 15 | int:TUBA1C |
| Interaction | CKAP2 interactions | 9.02e-06 | 126 | 164 | 8 | int:CKAP2 | |
| Interaction | YAP1 interactions | GPHN NCOA6 TES UBQLN1 TUBA1C TUBA3E NR1D1 CREBBP TUBA4A TUBA3C TUBA1B ARID1B KMT2D LATS1 TUBA1A YAP1 GLI1 ARID2 AHNAK RPRD2 SNRPB RPA1 EPB41L2 TMEM139 | 9.08e-06 | 1095 | 164 | 24 | int:YAP1 |
| Interaction | BAG2 interactions | NCOA2 NCOA6 TUBA1C BCORL1 PLEKHA4 CREBBP PHC1 YEATS2 SHROOM1 TUBA1A KCNH2 YAP1 AHNAK RPRD2 RPA1 SMAP2 NOS2 | 1.34e-05 | 622 | 164 | 17 | int:BAG2 |
| Interaction | GRM7 interactions | 1.49e-05 | 19 | 164 | 4 | int:GRM7 | |
| Interaction | FRMD8 interactions | 1.49e-05 | 19 | 164 | 4 | int:FRMD8 | |
| Interaction | CNN3 interactions | 1.55e-05 | 98 | 164 | 7 | int:CNN3 | |
| Interaction | KDM5B interactions | 1.76e-05 | 100 | 164 | 7 | int:KDM5B | |
| Interaction | ALG13 interactions | 1.95e-05 | 183 | 164 | 9 | int:ALG13 | |
| Interaction | NUMB interactions | 2.10e-05 | 232 | 164 | 10 | int:NUMB | |
| Interaction | BUB3 interactions | PLEKHA4 IKZF1 CLASP2 ZWINT KMT2D YAP1 SQSTM1 GLI1 RPA1 TP53BP1 | 2.10e-05 | 232 | 164 | 10 | int:BUB3 |
| Interaction | TOX4 interactions | 2.16e-05 | 142 | 164 | 8 | int:TOX4 | |
| Interaction | CDC20 interactions | TUBA1C PLEKHA4 CREBBP TUBA4A AXIN2 ZWINT TUBA1A PLEKHO2 YAP1 RPA1 | 2.27e-05 | 234 | 164 | 10 | int:CDC20 |
| Interaction | PSMC4 interactions | UBQLN1 PLEKHA4 IFI16 AHSA1 TUBA4A TUBA1B LATS1 SQSTM1 RORB RPA1 NOS2 TP53BP1 | 2.60e-05 | 344 | 164 | 12 | int:PSMC4 |
| Interaction | YWHAG interactions | GPHN NCOA6 TRPM7 DZIP1L PLEKHA4 CRTC1 R3HDM2 CLASP2 IFI16 PRPF40A TUBA4A TUBA3C FARP2 NHSL1 SHROOM1 LATS1 MTOR YAP1 SQSTM1 RBM15B PRKCE RPA1 SMAP2 NOS2 EPB41L2 | 2.66e-05 | 1248 | 164 | 25 | int:YWHAG |
| Interaction | MAP3K2 interactions | 2.87e-05 | 73 | 164 | 6 | int:MAP3K2 | |
| Interaction | GNA13 interactions | 2.91e-05 | 148 | 164 | 8 | int:GNA13 | |
| Interaction | MAP1LC3A interactions | UBQLN1 ANK2 TBC1D25 APOBR PRPF40A TUBA4A TUBA1B AP2A1 SQSTM1 TP53BP1 | 2.91e-05 | 241 | 164 | 10 | int:MAP1LC3A |
| Interaction | CST11 interactions | 3.36e-05 | 75 | 164 | 6 | int:CST11 | |
| Interaction | PPP1CC interactions | PLEKHA4 BAX TACC2 CREBBP PRPF40A PHC1 ZWINT LATS1 AP2A1 YAP1 PPP1R3F RPRD2 KLHL8 HDAC10 SPOCD1 RPA1 PSPC1 EPB41L2 | 3.36e-05 | 738 | 164 | 18 | int:PPP1CC |
| Interaction | GABRA1 interactions | 3.52e-05 | 152 | 164 | 8 | int:GABRA1 | |
| Interaction | MDC1 interactions | RAG1 PLEKHA4 ICE1 IFI16 CREBBP PHC1 ARID1B YAP1 RPRD2 HDAC10 SNRPB RPA1 TP53BP1 | 3.57e-05 | 414 | 164 | 13 | int:MDC1 |
| Interaction | CDK13 interactions | 3.69e-05 | 153 | 164 | 8 | int:CDK13 | |
| Interaction | YWHAQ interactions | NCOA6 TRPM7 TUBA1C PLEKHA4 BAX CRTC1 R3HDM2 CLASP2 MCCC1 CPS1 IFI16 ITGB4 TUBA3C NHSL1 SHROOM1 LATS1 TUBA1A MTOR YAP1 PRKCE RPA1 NOS2 EPB41L2 | 3.85e-05 | 1118 | 164 | 23 | int:YWHAQ |
| Interaction | CAD interactions | NCOA2 TES TUBA1C PLEKHA4 TUBA4A LATS1 TUBA1A YAP1 SQSTM1 MAP4K1 PRKCE RPA1 NOS2 | 3.94e-05 | 418 | 164 | 13 | int:CAD |
| Interaction | WWTR1 interactions | NCOA2 GPHN NCOA6 CREBBP PRPF40A YEATS2 ARID1B KMT2D LATS1 YAP1 ARID2 RPRD2 TP53BP1 | 4.34e-05 | 422 | 164 | 13 | int:WWTR1 |
| Interaction | FEV interactions | 4.41e-05 | 203 | 164 | 9 | int:FEV | |
| Interaction | CRX interactions | NCOA2 BCORL1 MDFI CREBBP NCOR2 ARID1B KMT2D ARID2 SMAP2 SEC14L4 | 4.55e-05 | 254 | 164 | 10 | int:CRX |
| Interaction | NUP35 interactions | NCOA2 NCOA6 PLEKHA4 IFI16 CREBBP PRPF40A YEATS2 NCOR2 ARID1B KMT2D GLI1 PSPC1 EPB41L2 | 4.56e-05 | 424 | 164 | 13 | int:NUP35 |
| Interaction | TBXT interactions | 4.61e-05 | 116 | 164 | 7 | int:TBXT | |
| Interaction | PTPRQ interactions | 4.68e-05 | 25 | 164 | 4 | int:PTPRQ | |
| Interaction | DYRK1A interactions | TES ADAM9 PLEKHA4 ICE1 MCCC1 ITGB4 CREBBP NCOR2 KMT2D SHROOM1 AP2A1 SQSTM1 GLI1 AHNAK PPP1R3F | 4.71e-05 | 552 | 164 | 15 | int:DYRK1A |
| Interaction | CBX4 interactions | TUBA1C PLEKHA4 CREBBP PRPF40A PHC1 TSPYL5 AP4M1 PSPC1 EPB41L2 | 4.76e-05 | 205 | 164 | 9 | int:CBX4 |
| Interaction | SEC16A interactions | TES PLEKHA4 R3HDM2 NCOR2 LATS1 AP2A1 TUBA1A YAP1 SQSTM1 AHNAK FAM83D RPA1 SMAP2 | 4.78e-05 | 426 | 164 | 13 | int:SEC16A |
| Interaction | TAF9 interactions | 4.85e-05 | 159 | 164 | 8 | int:TAF9 | |
| Interaction | RACGAP1 interactions | 5.32e-05 | 208 | 164 | 9 | int:RACGAP1 | |
| Interaction | TUBB2A interactions | TES TUBA1C PLEKHA4 AHSA1 TUBA4A SLC2A4 TUBA1B TUBA1A PTPRS YAP1 SQSTM1 | 5.79e-05 | 316 | 164 | 11 | int:TUBB2A |
| Interaction | DYNLL2 interactions | GPHN NCOA6 UBQLN1 DZIP1L NHSL1 YAP1 SQSTM1 FAM83D RPA1 TP53BP1 | 6.09e-05 | 263 | 164 | 10 | int:DYNLL2 |
| Interaction | RYK interactions | 6.17e-05 | 212 | 164 | 9 | int:RYK | |
| Interaction | PAF1 interactions | 6.63e-05 | 214 | 164 | 9 | int:PAF1 | |
| Interaction | HSPB1 interactions | TES TUBA1C PLEKHA4 MCCC1 CREBBP PRPF40A TUBA4A TUBA1B LATS1 USP38 YAP1 SQSTM1 AHNAK PRKCE RPA1 NOS2 EPB41L2 | 6.80e-05 | 708 | 164 | 17 | int:HSPB1 |
| Interaction | TMEM263 interactions | 6.82e-05 | 85 | 164 | 6 | int:TMEM263 | |
| Interaction | PML interactions | NCOA2 TES GATAD2A TUBA1C PLEKHA4 TACC2 IFI16 AHSA1 CREBBP PRPF40A TUBA3C YEATS2 NCOR2 PTPRF MTOR YAP1 SQSTM1 AHNAK EPB41L2 TP53BP1 | 7.36e-05 | 933 | 164 | 20 | int:PML |
| Interaction | LTA interactions | 7.43e-05 | 28 | 164 | 4 | int:LTA | |
| Interaction | PRPF40A interactions | UBQLN1 DZIP1L PLEKHA4 SYT2 IFI16 PRPF40A TUBA1B PTPRF TSPYL5 SNRPB RPA1 PSPC1 EPB41L2 | 7.61e-05 | 446 | 164 | 13 | int:PRPF40A |
| Interaction | PLK1 interactions | RBBP8 PLEKHA4 AHSA1 TUBA4A FARP2 PARP10 LATS1 TUBA1A MTOR SQSTM1 TRAK2 AP4M1 RPA1 TP53BP1 | 7.62e-05 | 510 | 164 | 14 | int:PLK1 |
| Interaction | PEX5L interactions | 7.69e-05 | 54 | 164 | 5 | int:PEX5L | |
| Interaction | TRMU interactions | 7.77e-05 | 87 | 164 | 6 | int:TRMU | |
| Interaction | GATA1 interactions | 8.10e-05 | 171 | 164 | 8 | int:GATA1 | |
| Interaction | KDM1A interactions | RBBP8 BCORL1 PLEKHA4 CRTC1 IKZF1 ICE1 MCCC1 PHC1 ZBP1 YEATS2 NCOR2 KMT2D USP38 YAP1 SQSTM1 AHNAK FAM9A RPA1 PSPC1 TP53BP1 | 8.27e-05 | 941 | 164 | 20 | int:KDM1A |
| Interaction | JPT2 interactions | 8.41e-05 | 55 | 164 | 5 | int:JPT2 | |
| Interaction | TES interactions | TES TUBA1C PLEKHA4 CPS1 AHSA1 TUBA4A TUBA1B YAP1 SQSTM1 NFYA RPA1 | 8.99e-05 | 332 | 164 | 11 | int:TES |
| Interaction | SIAH1 interactions | 9.09e-05 | 223 | 164 | 9 | int:SIAH1 | |
| Interaction | TPRX2 interactions | 9.17e-05 | 56 | 164 | 5 | int:TPRX2 | |
| Interaction | RABL6 interactions | 9.50e-05 | 130 | 164 | 7 | int:RABL6 | |
| Interaction | HDAC1 interactions | GATAD2A TRPM7 RBBP8 ZNF423 PLEKHA4 GON4L CRTC1 IKZF1 MCCC1 CREBBP TUBA1B YEATS2 NCOR2 KMT2D USP38 YAP1 SQSTM1 GLI1 GLI2 AHNAK NFYA RPA1 | 9.68e-05 | 1108 | 164 | 22 | int:HDAC1 |
| Interaction | TNRC6A interactions | NCOA6 GATAD2A R3HDM2 ITGB4 LATS1 AP2A1 SQSTM1 RPA1 PSPC1 TP53BP1 | 1.02e-04 | 280 | 164 | 10 | int:TNRC6A |
| Interaction | CRNKL1 interactions | 1.03e-04 | 177 | 164 | 8 | int:CRNKL1 | |
| Interaction | INSL5 interactions | 1.09e-04 | 58 | 164 | 5 | int:INSL5 | |
| Interaction | EIF2B1 interactions | 1.10e-04 | 133 | 164 | 7 | int:EIF2B1 | |
| Interaction | SMAD4 interactions | PDXDC1 COL5A1 UBQLN1 ZNF423 PLEKHA4 GATA6 BAX CREBBP PRPF40A ARID1B MTOR SQSTM1 GLI1 RPA1 | 1.14e-04 | 530 | 164 | 14 | int:SMAD4 |
| Interaction | RBBP5 interactions | NCOA6 GATAD2A INCENP PLEKHA4 CREBBP TUBA4A YEATS2 KMT2D TUBA1A RBM15B | 1.25e-04 | 287 | 164 | 10 | int:RBBP5 |
| Interaction | SMARCE1 interactions | NCOA2 PLEKHA4 IKZF1 PRPF40A ARID1B YAP1 GLI1 ARID2 RPA1 TP53BP1 | 1.25e-04 | 287 | 164 | 10 | int:SMARCE1 |
| Interaction | SOX17 interactions | 1.27e-04 | 95 | 164 | 6 | int:SOX17 | |
| Interaction | RNMT interactions | 1.27e-04 | 95 | 164 | 6 | int:RNMT | |
| Interaction | CTBP1 interactions | GATAD2A RBBP8 BCORL1 PLEKHA4 IKZF1 MCCC1 CREBBP ZBP1 YEATS2 NCOR2 RPA1 SNRPN | 1.27e-04 | 406 | 164 | 12 | int:CTBP1 |
| Interaction | CACYBP interactions | PLEKHA4 IFI16 AHSA1 TUBA4A YAP1 SQSTM1 AHNAK SNRPB RPA1 TP53BP1 | 1.29e-04 | 288 | 164 | 10 | int:CACYBP |
| Interaction | ATXN10 interactions | 1.32e-04 | 137 | 164 | 7 | int:ATXN10 | |
| Interaction | KIF5B interactions | NCOA2 PLEKHA4 TACC2 MCCC1 IFI16 SLC2A4 TUBA1A YAP1 SQSTM1 TRAK2 RPA1 | 1.36e-04 | 348 | 164 | 11 | int:KIF5B |
| Interaction | KLF15 interactions | 1.36e-04 | 290 | 164 | 10 | int:KLF15 | |
| Interaction | SRF interactions | 1.44e-04 | 139 | 164 | 7 | int:SRF | |
| Interaction | LGALS7 interactions | 1.44e-04 | 139 | 164 | 7 | int:LGALS7 | |
| Interaction | SMARCC2 interactions | GATAD2A PLEKHA4 IFI16 CREBBP PRPF40A ARID1B YAP1 GLI1 ARID2 RPA1 TP53BP1 | 1.54e-04 | 353 | 164 | 11 | int:SMARCC2 |
| Interaction | FAM76B interactions | 1.59e-04 | 99 | 164 | 6 | int:FAM76B | |
| Interaction | THTPA interactions | 1.61e-04 | 63 | 164 | 5 | int:THTPA | |
| Interaction | NUFIP2 interactions | PLEKHA4 MDFI IFI16 PRPF40A YEATS2 YAP1 GLI1 RBM15B TSPYL5 RPA1 PSPC1 EPB41L2 | 1.63e-04 | 417 | 164 | 12 | int:NUFIP2 |
| Interaction | NOL9 interactions | 1.65e-04 | 142 | 164 | 7 | int:NOL9 | |
| Interaction | FARP1 interactions | 1.65e-04 | 142 | 164 | 7 | int:FARP1 | |
| Cytoband | 12q13.12 | 1.16e-05 | 38 | 168 | 4 | 12q13.12 | |
| Cytoband | 3q27.1 | 1.32e-04 | 27 | 168 | 3 | 3q27.1 | |
| GeneFamily | Tubulins | 1.09e-10 | 26 | 105 | 7 | 778 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.03e-05 | 50 | 105 | 5 | 1293 | |
| GeneFamily | 5-hydroxytryptamine receptors, ionotropic | 3.30e-04 | 5 | 105 | 2 | 172 | |
| GeneFamily | SEC14 family|PRELI domain containing | 4.94e-04 | 6 | 105 | 2 | 1063 | |
| GeneFamily | Collagens | 2.41e-03 | 46 | 105 | 3 | 490 | |
| GeneFamily | AT-rich interaction domain containing | 3.34e-03 | 15 | 105 | 2 | 418 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.34e-03 | 15 | 105 | 2 | 82 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.29e-03 | 17 | 105 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.81e-03 | 18 | 105 | 2 | 91 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.53e-03 | 21 | 105 | 2 | 813 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.68e-03 | 66 | 105 | 3 | 722 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS | 5.08e-06 | 69 | 166 | 6 | M13133 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 5.52e-06 | 200 | 166 | 9 | M6620 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | COL5A1 TES TUBA1C MTSS1 GATA6 IFI16 ADGRA2 TUBA1B TUBA1A KCNH2 AHNAK TRPV2 SPOCD1 EPB41L2 | 1.63e-05 | 567 | 166 | 14 | M2129 |
| Coexpression | GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN | 2.29e-05 | 133 | 166 | 7 | M8181 | |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-08 | 200 | 168 | 9 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-08 | 200 | 168 | 9 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-08 | 200 | 168 | 9 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-08 | 200 | 168 | 9 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 7.27e-08 | 200 | 168 | 9 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 182 | 168 | 8 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-07 | 187 | 168 | 8 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.78e-07 | 187 | 168 | 8 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-07 | 189 | 168 | 8 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.52e-07 | 190 | 168 | 8 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.52e-07 | 190 | 168 | 8 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.52e-07 | 190 | 168 | 8 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.05e-07 | 192 | 168 | 8 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.05e-07 | 192 | 168 | 8 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.34e-07 | 193 | 168 | 8 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.34e-07 | 193 | 168 | 8 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.56e-07 | 197 | 168 | 8 | 04aaf35ef4db6325b2b2b92e93272f1973764b78 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 8.56e-07 | 197 | 168 | 8 | d8355f07a53e771052f9ab6b38814365dfe8d9ae | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.89e-07 | 198 | 168 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.59e-07 | 200 | 168 | 8 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 9.59e-07 | 200 | 168 | 8 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 179 | 168 | 7 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-06 | 180 | 168 | 7 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-06 | 180 | 168 | 7 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-06 | 180 | 168 | 7 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.95e-06 | 186 | 168 | 7 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 187 | 168 | 7 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 187 | 168 | 7 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 187 | 168 | 7 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 187 | 168 | 7 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.20e-06 | 187 | 168 | 7 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.45e-06 | 188 | 168 | 7 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.98e-06 | 190 | 168 | 7 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.98e-06 | 190 | 168 | 7 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.98e-06 | 190 | 168 | 7 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-06 | 192 | 168 | 7 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.84e-06 | 193 | 168 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Lymphoid|IPF / Disease state, Lineage and Cell class | 8.84e-06 | 193 | 168 | 7 | bf9d50aea909a28dd1d0933af33842d5f1ae7818 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-06 | 195 | 168 | 7 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.46e-06 | 195 | 168 | 7 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-06 | 195 | 168 | 7 | 34a9462f4e843f3065cc58c17ad71c1b5b836ae1 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 197 | 168 | 7 | f4dad4423384a2a25e064c849ffccf2811573be0 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 197 | 168 | 7 | cd7e34318b4ae72b7b312fda8cc0e041c2ac4ab5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.01e-05 | 197 | 168 | 7 | b2f4d7c301c0b24003374923b31d6d058e40b213 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-05 | 200 | 168 | 7 | 83afe771e9041c98703d8bad928a98cde601b704 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 200 | 168 | 7 | fe22f7c97f4e37dfa7881d0f1d9245c1237d873b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.11e-05 | 200 | 168 | 7 | f611335436bb74d22496f7872dff2110c3d3061f | |
| ToppCell | Sigmoid-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 1.11e-05 | 200 | 168 | 7 | 372fe9018481a4e9ac6ab3af43705a48238c4376 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-05 | 200 | 168 | 7 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Glia_progenitor_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 200 | 168 | 7 | 4b937b1d0179d1d0e51931f35720e205d460a07e | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.18e-05 | 96 | 168 | 5 | a48235df1f5526ce3ffc4c0c2ba038eb20229c55 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Klk6_(Klk6)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.18e-05 | 96 | 168 | 5 | 0fc179af7370a29b7bd5d81e1302a479ae72f196 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2-Trf|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.18e-05 | 96 | 168 | 5 | c301ecfd67ece8bb12be1b94b614957a58046457 | |
| ToppCell | Cerebellum-Macroglia-OLIGODENDROCYTE-O2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.18e-05 | 96 | 168 | 5 | 7d402d543ff159c9bb84c00b083e6e18fc0ff786 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 3.50e-05 | 162 | 168 | 6 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 164 | 168 | 6 | b175258fb0885afd84d4a414c0ae441f880e8469 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.75e-05 | 164 | 168 | 6 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 164 | 168 | 6 | 875d922eec7e3df0998ddf0c8c4dee2dcd5b23ca | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 164 | 168 | 6 | 8bcfc93220d7c99dddb32b7fa7fb9aec2a1c63fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 166 | 168 | 6 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 166 | 168 | 6 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 167 | 168 | 6 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 170 | 168 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.89e-05 | 172 | 168 | 6 | 55fba5ce0ead1114e1a76f67ad68432c6bac90e5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-05 | 176 | 168 | 6 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.74e-05 | 177 | 168 | 6 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.92e-05 | 178 | 168 | 6 | 8ec2a25dda96c9cc9c2904b6cb18f75a293f4969 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.92e-05 | 178 | 168 | 6 | 6c91331196696e0cf239d105f458e3230659fa38 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.11e-05 | 179 | 168 | 6 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 6.30e-05 | 180 | 168 | 6 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-05 | 181 | 168 | 6 | fc51468c74534b60b4e786bd512d0f1c5dc05de7 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.49e-05 | 181 | 168 | 6 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.49e-05 | 181 | 168 | 6 | 0c3f469bed108994ed696230e3c30343f7a301d3 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.49e-05 | 181 | 168 | 6 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.69e-05 | 182 | 168 | 6 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.90e-05 | 183 | 168 | 6 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.90e-05 | 183 | 168 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.11e-05 | 184 | 168 | 6 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 7.11e-05 | 184 | 168 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | e33bb572af9dfd11127105f1ac99bc958a7cafbb | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.23e-05 | 114 | 168 | 5 | 2cc5d2da5573650c5232a01e2d2128082c4bffcb | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Pdgfa_(Mural.Rgs5Acta2.Pdgfa)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.23e-05 | 114 | 168 | 5 | fceb7cc590a47380145fc0d854c9f2350dbb0a59 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.33e-05 | 185 | 168 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 7.33e-05 | 185 | 168 | 6 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.33e-05 | 185 | 168 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.55e-05 | 186 | 168 | 6 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-05 | 186 | 168 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.55e-05 | 186 | 168 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.77e-05 | 187 | 168 | 6 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | (04)_Pre-ciliated-(3)_72hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 8.00e-05 | 188 | 168 | 6 | f911dc61b008b60aaa2a1e9354085f480a669e2c | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.00e-05 | 188 | 168 | 6 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.00e-05 | 188 | 168 | 6 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.24e-05 | 189 | 168 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.24e-05 | 189 | 168 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.24e-05 | 189 | 168 | 6 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 8.48e-05 | 190 | 168 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.48e-05 | 190 | 168 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| Drug | Epothilone D | 1.43e-08 | 12 | 165 | 5 | DB01873 | |
| Drug | Epothilone B | 1.43e-08 | 12 | 165 | 5 | DB03010 | |
| Drug | evodiamine | 1.01e-06 | 73 | 165 | 7 | CID000151289 | |
| Drug | indibulin | 1.09e-06 | 26 | 165 | 5 | CID000002929 | |
| Drug | JK184 | 1.49e-06 | 4 | 165 | 3 | ctd:C525593 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 1.49e-06 | 4 | 165 | 3 | DB07574 | |
| Drug | fulvestrant | NCOA2 RBBP8 BAX PTGER4 CREBBP SLC2A4 ZWINT TUBA1B NCOR2 MTOR GLI1 AHNAK TRAK2 CDH2 NOS2 | 2.59e-06 | 484 | 165 | 15 | ctd:C070081 |
| Drug | AC1L8WWP | 3.18e-06 | 56 | 165 | 6 | CID000388944 | |
| Drug | discodermolide | 5.12e-06 | 35 | 165 | 5 | CID000643668 | |
| Drug | DTAF | 6.80e-06 | 37 | 165 | 5 | CID000123934 | |
| Drug | albendazole | 6.80e-06 | 37 | 165 | 5 | CID000002082 | |
| Drug | baccatin III | 6.80e-06 | 37 | 165 | 5 | CID000065366 | |
| Drug | CRA-026440 | 7.36e-06 | 6 | 165 | 3 | CID011619469 | |
| Drug | erianin | 8.87e-06 | 39 | 165 | 5 | CID000356759 | |
| Drug | amoebal | 1.14e-05 | 41 | 165 | 5 | CID000001985 | |
| Drug | lumicolchicine | 1.14e-05 | 41 | 165 | 5 | CID000072624 | |
| Drug | Glucose | COL5A1 CCDC60 TRPM7 BAX CLASP2 PTGER4 ADGRA2 CREBBP PRPF40A SLC2A4 ZWINT NHSL1 MFAP3 TUBA1A MTOR KCNH2 YAP1 GLI1 ARID2 PVR PCNX1 KLHL8 MBD5 RPA1 NOS2 TP53BP1 | 1.16e-05 | 1420 | 165 | 26 | ctd:D005947 |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.36e-05 | 196 | 165 | 9 | 3793_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.36e-05 | 196 | 165 | 9 | 1494_UP | |
| Drug | bromocolchicine | 1.45e-05 | 21 | 165 | 4 | CID000161518 | |
| Drug | colchifoline | 1.45e-05 | 21 | 165 | 4 | CID000100132 | |
| Drug | Ustiloxin A | 1.45e-05 | 21 | 165 | 4 | CID000164454 | |
| Drug | SRI-3072 | 1.45e-05 | 21 | 165 | 4 | CID000493469 | |
| Drug | Stylophorin | 1.45e-05 | 43 | 165 | 5 | CID000010147 | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.48e-05 | 198 | 165 | 9 | 3941_UP | |
| Drug | Vincristine | RBBP8 TUBA3D TUBA1C BAX GON4L CLASP2 PTGER4 CREBBP TENM2 TUBA4A TUBA3C NHSL1 TUBA1B XIRP2 SQSTM1 GLI1 ARID2 TRPV2 FAM83D PRKCE PCNX1 PSPC1 SNRPN | 1.52e-05 | 1182 | 165 | 23 | ctd:D014750 |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 1.54e-05 | 199 | 165 | 9 | 2683_DN | |
| Drug | A805480 | 1.63e-05 | 44 | 165 | 5 | CID000620368 | |
| Drug | Deoxyglucose | 1.63e-05 | 74 | 165 | 6 | ctd:D003847 | |
| Drug | 3,4,5-trimethoxyacetophenone | 1.76e-05 | 22 | 165 | 4 | CID000014345 | |
| Drug | AC1L1GIQ | 1.76e-05 | 22 | 165 | 4 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 1.76e-05 | 22 | 165 | 4 | CID000098538 | |
| Drug | SureCN13401588 | 1.76e-05 | 22 | 165 | 4 | CID009897422 | |
| Drug | N-methyldemecolcine | 1.76e-05 | 22 | 165 | 4 | CID000023759 | |
| Drug | NSC-339672 | 1.76e-05 | 22 | 165 | 4 | CID000433930 | |
| Drug | methyl ether | 1.82e-05 | 45 | 165 | 5 | CID000008254 | |
| Drug | Androstenedione | 1.82e-05 | 45 | 165 | 5 | ctd:D000735 | |
| Drug | diallyl tetrasulfide | 1.98e-05 | 114 | 165 | 7 | CID000075552 | |
| Drug | epo906 | 1.98e-05 | 114 | 165 | 7 | CID000388945 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 2.11e-05 | 23 | 165 | 4 | CID000006858 | |
| Drug | AC1L2P05 | 2.11e-05 | 23 | 165 | 4 | CID000125688 | |
| Drug | 2,3,4-tabp | 2.11e-05 | 23 | 165 | 4 | CID000125548 | |
| Drug | NSC-373301 | 2.11e-05 | 23 | 165 | 4 | CID000341375 | |
| Drug | NSC355636 | 2.11e-05 | 23 | 165 | 4 | CID000100176 | |
| Drug | IKP104 | 2.11e-05 | 23 | 165 | 4 | CID000130739 | |
| Drug | fluorescein-colchicine | 2.11e-05 | 23 | 165 | 4 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 2.11e-05 | 23 | 165 | 4 | CID000084076 | |
| Drug | 2,3,4-TCB | 2.11e-05 | 23 | 165 | 4 | CID000129239 | |
| Drug | N-acetylcolchinol | 2.11e-05 | 23 | 165 | 4 | CID000097865 | |
| Drug | parbendazole | 2.52e-05 | 24 | 165 | 4 | CID000026596 | |
| Drug | tropolone methyl ether | 2.52e-05 | 24 | 165 | 4 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 2.52e-05 | 24 | 165 | 4 | CID000330401 | |
| Drug | NABV | 2.52e-05 | 24 | 165 | 4 | CID000175959 | |
| Drug | AC1L4TG7 | 2.52e-05 | 24 | 165 | 4 | CID000163705 | |
| Drug | moscatilin | 2.52e-05 | 24 | 165 | 4 | CID000176096 | |
| Drug | NSC-36768 | 2.52e-05 | 24 | 165 | 4 | CID000165441 | |
| Drug | deacetamidocolchicine | 2.52e-05 | 24 | 165 | 4 | CID000014995 | |
| Drug | colchicide | 2.52e-05 | 24 | 165 | 4 | CID000120712 | |
| Drug | C22H22O8 | 2.69e-05 | 164 | 165 | 8 | CID000004865 | |
| Drug | NSC91998 | 2.74e-05 | 81 | 165 | 6 | CID000005668 | |
| Drug | NSC654663 | 2.77e-05 | 49 | 165 | 5 | CID000375252 | |
| Drug | mpMap | 2.99e-05 | 25 | 165 | 4 | CID000100806 | |
| Drug | AC1Q6P06 | 2.99e-05 | 25 | 165 | 4 | CID000160263 | |
| Drug | allocolchicine | 2.99e-05 | 25 | 165 | 4 | CID000196989 | |
| Drug | 1069C85 | 2.99e-05 | 25 | 165 | 4 | CID006918099 | |
| Drug | 55623-37-5 | 2.99e-05 | 25 | 165 | 4 | CID006438440 | |
| Drug | MDL 27048 | 2.99e-05 | 25 | 165 | 4 | CID006439188 | |
| Drug | NBD-colcemid | 2.99e-05 | 25 | 165 | 4 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 2.99e-05 | 25 | 165 | 4 | CID000043264 | |
| Drug | CA1P | 2.99e-05 | 25 | 165 | 4 | CID006918545 | |
| Drug | peloruside A | 2.99e-05 | 25 | 165 | 4 | CID006918506 | |
| Drug | NSC142227 | 2.99e-05 | 25 | 165 | 4 | CID000073427 | |
| Drug | Z)-combretastatin A-4 | 3.06e-05 | 50 | 165 | 5 | CID000072686 | |
| Drug | NSC527981 | 3.51e-05 | 26 | 165 | 4 | CID000352796 | |
| Drug | NSC332029 | 3.51e-05 | 26 | 165 | 4 | CID000100073 | |
| Drug | pironetin | 3.51e-05 | 26 | 165 | 4 | CID006438891 | |
| Drug | isaxonine | 3.51e-05 | 26 | 165 | 4 | CID000071169 | |
| Drug | magnesium sulfate | 3.71e-05 | 52 | 165 | 5 | CID000024083 | |
| Drug | vinflunine | 3.71e-05 | 52 | 165 | 5 | CID000157688 | |
| Drug | 2-(N-morpholino)ethanesulfonic acid | 3.85e-05 | 86 | 165 | 6 | CID000078165 | |
| Drug | AC1L1J4H | 4.10e-05 | 27 | 165 | 4 | CID000004862 | |
| Drug | dinitroanilines | 4.10e-05 | 27 | 165 | 4 | CID000136400 | |
| Drug | NSC292222 | 4.10e-05 | 27 | 165 | 4 | CID000099957 | |
| Drug | NSC D-669356 | 4.10e-05 | 27 | 165 | 4 | CID000178028 | |
| Drug | AC1L1FWN | 4.33e-05 | 227 | 165 | 9 | CID000003425 | |
| Drug | allicin | 4.47e-05 | 54 | 165 | 5 | CID000065036 | |
| Drug | AC1L1KMJ | COL5A1 COL10A1 ANK2 NOX5 TUBA1C TUBA3E TUBA4A SLC2A4 TUBA1A MTOR PRKCE CDH2 NOS2 | 4.61e-05 | 476 | 165 | 13 | CID000030956 |
| Drug | NSC 370147 | 4.75e-05 | 28 | 165 | 4 | CID000182762 | |
| Drug | NSC72302 | 4.75e-05 | 28 | 165 | 4 | CID000118078 | |
| Drug | Isoproterenol | PDXDC1 COL5A1 MTSS1 BAX TACC2 CPS1 ZNF236 RSC1A1 TUBA4A SLC2A4 TUBA1B PTPRF MTOR SQSTM1 PVR PRKCE MBD5 SNRPB CDH2 NOS2 | 4.89e-05 | 1016 | 165 | 20 | ctd:D007545 |
| Drug | bp U | 5.48e-05 | 29 | 165 | 4 | CID000368697 | |
| Drug | oxibendazole | 5.48e-05 | 29 | 165 | 4 | CID000004622 | |
| Drug | Aids106696 | 5.48e-05 | 29 | 165 | 4 | CID006475933 | |
| Drug | ddGDP | 5.48e-05 | 29 | 165 | 4 | CID000134739 | |
| Drug | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane | 5.91e-05 | 11 | 165 | 3 | ctd:C492909 | |
| Drug | benzimidazole | 5.99e-05 | 93 | 165 | 6 | CID000005798 | |
| Drug | AC1NBBHE | 6.29e-05 | 30 | 165 | 4 | CID004490620 | |
| Drug | eleutherobin | 6.29e-05 | 30 | 165 | 4 | CID006918335 | |
| Drug | azatoxin | 6.29e-05 | 30 | 165 | 4 | CID000125383 | |
| Drug | NSC617668 | 6.29e-05 | 30 | 165 | 4 | CID000357989 | |
| Disease | microlissencephaly (implicated_via_orthology) | 1.15e-15 | 8 | 164 | 7 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 1.15e-15 | 8 | 164 | 7 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 1.15e-15 | 8 | 164 | 7 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 1.56e-12 | 27 | 164 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | platelet crit | NCOA2 GATAD2A BAX IKZF1 ADGRV1 CPS1 ARHGEF11 APOBR KIAA1614 USP38 PLEKHO2 EXOC3L4 NCAN PRKCE RPRD2 KLHL8 EPB41L2 CCDC40 | 6.42e-06 | 952 | 164 | 18 | EFO_0007985 |
| Disease | sinoatrial node disease (implicated_via_orthology) | 3.07e-05 | 2 | 164 | 2 | DOID:0050824 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | NCOA2 NCOA6 XIRP1 ANK2 SLCO2B1 BCORL1 FRMPD1 BAX TACC2 ARID1B KMT2D MTOR YAP1 GLI1 SPOCD1 CDH2 NOS2 TP53BP1 | 3.20e-05 | 1074 | 164 | 18 | C0006142 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.78e-04 | 147 | 164 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | glycine measurement, amino acid measurement | 1.83e-04 | 4 | 164 | 2 | EFO_0005134, EFO_0009767 | |
| Disease | phosphatidylcholine measurement | 2.00e-04 | 284 | 164 | 8 | EFO_0010226 | |
| Disease | Colonic Neoplasms | 2.14e-04 | 152 | 164 | 6 | C0009375 | |
| Disease | Diffuse Large B-Cell Lymphoma | 2.52e-04 | 55 | 164 | 4 | C0079744 | |
| Disease | Malignant tumor of colon | 2.72e-04 | 159 | 164 | 6 | C0007102 | |
| Disease | insulin resistance | 3.30e-04 | 59 | 164 | 4 | EFO_0002614 | |
| Disease | FEV change measurement, response to zileuton | 3.54e-04 | 25 | 164 | 3 | EFO_0005921, EFO_0007676 | |
| Disease | red blood cell density measurement | PDXDC1 PKP4 CRTC1 R3HDM2 IKZF1 ADGRV1 CPS1 ARHGEF11 FARP2 ARID1B PTPRF ARID2 PRKCE KLHL8 | 4.22e-04 | 880 | 164 | 14 | EFO_0007978 |
| Disease | osteoarthritis biomarker measurement | 4.54e-04 | 6 | 164 | 2 | EFO_0005890 | |
| Disease | level of Phosphatidylcholine (18:1_20:3) in blood serum | 4.54e-04 | 6 | 164 | 2 | OBA_2045103 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 4.99e-04 | 28 | 164 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | cortical thickness | NCOA2 TES GATAD2A ZNF423 FAT3 SIDT1 TACC2 SYT2 ADGRV1 ADGRA2 TENM2 KIAA1614 NHSL1 ARID1B PTPRF KLHL8 | 5.00e-04 | 1113 | 164 | 16 | EFO_0004840 |
| Disease | long QT syndrome (is_implicated_in) | 6.33e-04 | 7 | 164 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | metabolite measurement, diet measurement | 6.69e-04 | 71 | 164 | 4 | EFO_0004725, EFO_0008111 | |
| Disease | level of Sterol ester (27:1/20:4) in blood serum | 6.76e-04 | 31 | 164 | 3 | OBA_2045198 | |
| Disease | cancer (implicated_via_orthology) | 7.82e-04 | 268 | 164 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.01e-04 | 195 | 164 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | Chloracne | 8.14e-04 | 33 | 164 | 3 | C0263454 | |
| Disease | Endotoxemia | 8.41e-04 | 8 | 164 | 2 | C0376618 | |
| Disease | glycine measurement | 1.03e-03 | 137 | 164 | 5 | EFO_0009767 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.08e-03 | 9 | 164 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | platelet component distribution width | PRUNE2 TUBA1C MTSS1 IKZF1 CPS1 TUBA4A NCOR2 PLEKHO2 EXOC3L4 PVR SMAP2 CCDC40 | 1.10e-03 | 755 | 164 | 12 | EFO_0007984 |
| Disease | Bladder Neoplasm | 1.14e-03 | 140 | 164 | 5 | C0005695 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.14e-03 | 286 | 164 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | Malignant neoplasm of urinary bladder | 1.17e-03 | 141 | 164 | 5 | C0005684 | |
| Disease | tauopathy (implicated_via_orthology) | 1.34e-03 | 10 | 164 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement | 1.34e-03 | 10 | 164 | 2 | EFO_0800499 | |
| Disease | cortical surface area measurement | NCOA2 TES ZNF423 FAT3 TUBA1C SIDT1 SYT2 ADGRV1 CPS1 ADGRA2 TENM2 KIAA1614 NHSL1 ARID1B PTPRF USP38 TUBA1A | 1.38e-03 | 1345 | 164 | 17 | EFO_0010736 |
| Disease | Stomach Neoplasms | 1.42e-03 | 297 | 164 | 7 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.50e-03 | 300 | 164 | 7 | C0024623 | |
| Disease | urate measurement | ATP8B3 NCOA6 GON4L FRMD8 R3HDM2 ADGRV1 CPS1 FARP2 PTPRF USP38 GLI1 MBD5 EPB41L2 | 1.54e-03 | 895 | 164 | 13 | EFO_0004531 |
| Disease | periodontitis | 1.59e-03 | 223 | 164 | 6 | EFO_0000649 | |
| Disease | follistatin measurement | 1.63e-03 | 11 | 164 | 2 | EFO_0010614 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.67e-03 | 225 | 164 | 6 | EFO_0008317, EFO_0010351 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.83e-03 | 93 | 164 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | PIK3AP1 TRPM7 GON4L CPS1 ARHGEF11 TENM2 FARP2 NCOR2 AHNAK EXOC3L4 KLHL8 CSMD1 TP53BP1 | 1.85e-03 | 914 | 164 | 13 | EFO_0004532 |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.89e-03 | 157 | 164 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | Royer Syndrome | 1.95e-03 | 12 | 164 | 2 | C0265222 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 2.15e-03 | 46 | 164 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Liver carcinoma | 2.20e-03 | 507 | 164 | 9 | C2239176 | |
| Disease | uric acid measurement | TRPM7 FAT3 FRMD8 ADGRV1 CPS1 TENM2 FARP2 PLEKHH1 RPA1 EPB41L2 | 2.27e-03 | 610 | 164 | 10 | EFO_0004761 |
| Disease | Coffin-Siris syndrome | 2.30e-03 | 13 | 164 | 2 | C0265338 | |
| Disease | colon carcinoma (is_marker_for) | 2.30e-03 | 13 | 164 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Prader-Willi Syndrome | 2.30e-03 | 13 | 164 | 2 | C0032897 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.30e-03 | 13 | 164 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Disease Exacerbation | 2.34e-03 | 165 | 164 | 5 | C0235874 | |
| Disease | Prostatic Neoplasms | 2.43e-03 | 616 | 164 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.43e-03 | 616 | 164 | 10 | C0376358 | |
| Disease | immature platelet count | 2.94e-03 | 106 | 164 | 4 | EFO_0803544 | |
| Disease | Lymphoma, Follicular, Grade 2 | 3.07e-03 | 15 | 164 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 3.07e-03 | 15 | 164 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 3.07e-03 | 15 | 164 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 3.07e-03 | 15 | 164 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 3.07e-03 | 15 | 164 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 3.07e-03 | 15 | 164 | 2 | C0079758 | |
| Disease | Streptozotocin Diabetes | 3.15e-03 | 108 | 164 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 3.15e-03 | 108 | 164 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 3.15e-03 | 108 | 164 | 4 | C0002152 | |
| Disease | fibrinogen measurement | 3.25e-03 | 109 | 164 | 4 | EFO_0004623 | |
| Disease | Breast Carcinoma | 3.27e-03 | 538 | 164 | 9 | C0678222 | |
| Disease | body surface area | 3.30e-03 | 643 | 164 | 10 | EFO_0022196 | |
| Disease | level of triacylglycerol (56:6) in blood serum | 3.50e-03 | 16 | 164 | 2 | OBA_2020007 | |
| Disease | Romano-Ward Syndrome | 3.50e-03 | 16 | 164 | 2 | C0035828 | |
| Disease | response to triptolide, cytotoxicity measurement | 3.50e-03 | 16 | 164 | 2 | EFO_0006952, EFO_0007662 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.50e-03 | 16 | 164 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 3.58e-03 | 55 | 164 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | Neoplasm Invasiveness | 3.74e-03 | 184 | 164 | 5 | C0027626 | |
| Disease | hippocampal atrophy | 3.77e-03 | 56 | 164 | 3 | EFO_0005039 | |
| Disease | blood urea nitrogen measurement | 3.91e-03 | 452 | 164 | 8 | EFO_0004741 | |
| Disease | Liver Cirrhosis, Experimental | PRUNE2 COL5A1 TES R3HDM2 CPS1 PLEKHH1 NCOR2 AHNAK TRAK2 NOS2 EPB41L2 | 4.14e-03 | 774 | 164 | 11 | C0023893 |
| Disease | mean platelet volume | TUBA1C BCORL1 SIDT1 CRTC1 IKZF1 CPS1 APOBR PLEKHO2 EXOC3L4 PVR HTR3D KLHL8 SMAP2 | 4.71e-03 | 1020 | 164 | 13 | EFO_0004584 |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.72e-03 | 121 | 164 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | colorectal cancer (is_implicated_in) | 4.72e-03 | 121 | 164 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | PIK3AP1 TRPM7 R3HDM2 IKZF1 SLC2A4 WDR91 NCOR2 MTOR GLI1 KLHL8 CSMD1 SNRPN | 4.78e-03 | 904 | 164 | 12 | EFO_0004736 |
| Disease | pain | 4.88e-03 | 196 | 164 | 5 | EFO_0003843 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 4.93e-03 | 19 | 164 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | methadone dose measurement | 5.01e-03 | 62 | 164 | 3 | EFO_0007907 | |
| Disease | loneliness measurement | 5.15e-03 | 124 | 164 | 4 | EFO_0007865 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 5.24e-03 | 63 | 164 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | end stage renal disease (implicated_via_orthology) | 5.46e-03 | 20 | 164 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | Lymphoma, Follicular | 5.46e-03 | 20 | 164 | 2 | C0024301 | |
| Disease | pulmonary hypertension (is_marker_for) | 5.48e-03 | 64 | 164 | 3 | DOID:6432 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPGGNGPSVLSDETM | 921 | Q99569 | |
| QATPEVPSGVMNGVS | 101 | Q17RC7 | |
| VSCGNPGTPTNGMIV | 2976 | Q96PZ7 | |
| PGTPTNGMIVSSDGI | 2981 | Q96PZ7 | |
| QEESETQGPMSPLGD | 266 | Q99708 | |
| QMPGPAEAELTGGSE | 391 | A5X5Y0 | |
| PTMNGESVDPVGQPA | 166 | O95433 | |
| GLQLEGEPMLTPSEG | 1241 | Q96PE1 | |
| SVQPSGGDIRMNQGP | 936 | Q5H9F3 | |
| SGMPPAGGEISKSTQ | 6186 | Q8WXG9 | |
| SMGISGLQQDPSPAG | 126 | O15085 | |
| MGPGVNPTTPEAEEN | 186 | A8MVX0 | |
| GNGEISPMEPQGTLD | 1386 | Q68CP9 | |
| SSNDINGGMEPTPST | 636 | O95782 | |
| LGQMGQPGLGADSTP | 2271 | Q92793 | |
| APETMPSEQFGGSRG | 561 | Q9Y2T1 | |
| GDINIEGPSMNIEGP | 3501 | Q09666 | |
| PSGPTDTAQAMENGL | 231 | Q6MZZ7 | |
| QMMGGPLQSSSSEGP | 1516 | Q8NFD5 | |
| PEGPTSMGSLGQRED | 81 | O60423 | |
| EMLQASTSNPIPGDG | 461 | Q6ZUJ8 | |
| GSQLSGLFQMDVPGP | 371 | O00189 | |
| GGSSPQSSMISVNPG | 246 | Q8IWA6 | |
| LANFSSGPEGGVMQP | 31 | Q14894 | |
| SGVSPSGPGVVVMQL | 696 | Q9Y2K5 | |
| GFTMNPQASLGDPLG | 1016 | P15918 | |
| ATQATPSGLGTEGMP | 796 | Q8NDT2 | |
| VGNGDLIQMEGSPPE | 306 | O95755 | |
| GESQAGEQPTQTVMP | 391 | Q9NQX3 | |
| SGMPSRQLEEPGAGT | 311 | Q96P11 | |
| MNTSGDPAQTGPEGC | 1 | Q96PH1 | |
| AGSPCGSLMEGTPQI | 2211 | Q01484 | |
| QPPGQGSGTLVQSMV | 661 | Q8IYY4 | |
| SQLTPMGEGDELSGQ | 651 | P35228 | |
| NTDGDMRVTPEPGAG | 41 | Q86YP4 | |
| GEQTEPSRMGSKSPG | 2246 | Q9Y618 | |
| PGTEIFNMPAITGTG | 2306 | Q9Y618 | |
| VSPEDPGMGSQVQPG | 376 | O60320 | |
| LMATPQDPKGQGVGT | 236 | Q9NQS7 | |
| PSGRPGMQNGTGQTD | 341 | O95835 | |
| MPSGFQQIGSEDGEP | 1 | P14672 | |
| MDGTEGSAGQPGPAE | 1 | Q9BZ67 | |
| SPDGQLMSPGENGEV | 381 | Q02156 | |
| MDGTEGSVGQPGPTE | 1 | Q9BZ68 | |
| NMIPGSPGSTELEGG | 866 | Q12809 | |
| APMTPESSGPGGQAQ | 751 | Q5VZ46 | |
| TEEMNGKEISPGSGP | 706 | O43491 | |
| QEGSRATMPQVPGGS | 821 | Q5SYE7 | |
| DSNGPSDPGGGIEMS | 116 | Q96RV3 | |
| STVAPMNTPRGGVGS | 441 | Q9P2G9 | |
| ESPSVGEGPQGVTSM | 646 | O43312 | |
| PGVPGMGLAQEDTTS | 416 | P35408 | |
| DIPGPLQGSGQDMVS | 46 | Q6P996 | |
| DIPGPLQGSGQDMVS | 46 | Q6P474 | |
| GEEMPGLSVSEVGTQ | 396 | Q9H4H8 | |
| EGDMSSPNSTGIQDP | 196 | P08151 | |
| EPEVGTSMVGSGLNP | 706 | P08151 | |
| LGSAPNNDSGVEMPG | 671 | P10070 | |
| NNDSGVEMPGTGPGS | 676 | P10070 | |
| MPIPEDLSTTSGGQQ | 31 | Q13422 | |
| DPQEGTTPLMGQAGT | 246 | Q96FE7 | |
| MEGDGAPGPNSTVLV | 686 | P16144 | |
| INPEMGRSNSPGGDS | 286 | P55082 | |
| APSGLQEPSGMNAEG | 541 | Q7Z442 | |
| GGQFLTPLGSPEDMD | 1166 | Q13332 | |
| PPGVNSMDVAAGTAS | 126 | O75400 | |
| SGSEAPSVPGGPNNM | 1136 | Q14686 | |
| DLQSMGTGPDGSPLF | 336 | Q9Y3R4 | |
| GSGIASNFPGQPTME | 31 | Q8IZU1 | |
| NGSPPGSLQVAMEDS | 96 | P20393 | |
| RPQPQNGSSGMGSTV | 141 | P27694 | |
| AGAPVMTGAGESTNP | 541 | Q92908 | |
| MANPIIGNGGAPDTT | 96 | P31327 | |
| SAIGDPEGQMQATPE | 266 | Q969S8 | |
| DTEGSSPISGMPQNE | 1326 | Q9Y2F5 | |
| SPQPGFGMSGEELSE | 996 | Q2UY09 | |
| PGNMGTGVPASEQIS | 6 | Q9HCG7 | |
| PENPGQPSMGIDIAS | 426 | Q6UUV9 | |
| SPTVSSLQDMQGEPG | 881 | Q5SYB0 | |
| EQPRGGGPTSSEQIM | 6 | Q07812 | |
| LGPSEQMGQVTSGPA | 166 | Q4G0X9 | |
| GSTEEPQGQVLPMGV | 186 | Q4G0X9 | |
| AVSMNQGTEPTGPAD | 4486 | Q8TDW7 | |
| PQMNSEGEIPSLPSG | 171 | Q3T8J9 | |
| QLGSDVPDPGMVNEG | 606 | Q13443 | |
| SPSEIGPGMPANQDT | 426 | P20908 | |
| EGSLEEAATPMPQGN | 51 | Q99750 | |
| GMEQTTPGAGPDVPQ | 6 | Q96PG1 | |
| EEQTQPPSPAGAGMS | 146 | Q16666 | |
| SSQETQGGPLAPMTG | 641 | Q96RQ3 | |
| PTANMLLPTGEGQSG | 626 | Q9P267 | |
| NSPVEGAPLSGQDMT | 76 | Q8N4M1 | |
| GPLQMIVNTSGGPEF | 351 | Q8TE68 | |
| PESQLGGPGMVTDAE | 186 | Q86UP8 | |
| PESQLGGPGMVTDAE | 186 | Q6EKJ0 | |
| QDGPQPSSGLEGMVR | 1036 | O94887 | |
| LPGMLGSGETDFGPQ | 66 | Q86WA6 | |
| SSGQSPDVGNPMSLA | 16 | Q92681 | |
| SPFQGMGGEESQSPT | 336 | Q5VT52 | |
| QLPVEFGGTMTDPDG | 236 | Q9UDX3 | |
| QLPVEFGGTMTDPDG | 236 | B5MCN3 | |
| LASDNGIPPMSGTGT | 576 | P19022 | |
| PTDVVLEVGPGTGNM | 56 | Q9UNQ2 | |
| IPPSSQEVMPGGSVN | 236 | P10586 | |
| PFPGQMVDVSGTGTL | 731 | Q9Y5E6 | |
| QEPGQSGTSLRTGPM | 326 | Q53GL7 | |
| QEQEGPMSLGPVGSA | 371 | Q53GL7 | |
| TSTGQPIMVQAVPGG | 71 | P23511 | |
| QGDALASGPVETGPM | 1241 | P42345 | |
| PMDSTSVGGGLQEPE | 31 | Q6P0A1 | |
| PGSMGDDGQLSPGVL | 411 | Q92918 | |
| SDLGGMPNTSQVPGF | 181 | P15151 | |
| TMPIGPVDNSTESGG | 21 | Q8N9I0 | |
| QGPKQMNIPGGDRST | 201 | Q9UGI8 | |
| QLPAGPEGLDGMGTN | 531 | Q8WUY3 | |
| GPSQQVMTPQGRGTV | 136 | P63162 | |
| PSTQEASPTGDMAVG | 566 | Q3MII6 | |
| MTGGNLDSQGDPLPG | 691 | Q9H4M7 | |
| VGSMATAPQGLSPQE | 76 | O95177 | |
| QGGMEASAQPPTSEA | 501 | O14594 | |
| GTQPPGMGEALLGSE | 781 | O94933 | |
| ELPGPSGDNGISVTM | 41 | Q96QK8 | |
| LPETQPQGSMNLDSG | 276 | Q2M3G4 | |
| GPSQQVMTPQGRGTV | 136 | P14678 | |
| GLPGNDDVATMPSGG | 421 | Q9NT68 | |
| LDPPTQNSCSGMGGD | 1091 | Q9NZP6 | |
| GELQSLQMPESEGPS | 351 | Q13501 | |
| SAGQMPGPGEAELTG | 386 | Q70Z44 | |
| GQGPELMGGAQTPTK | 561 | Q0VD83 | |
| GTPLVSANQGVTGMP | 536 | Q03692 | |
| MVSQSQPGSRSGSPG | 451 | O75122 | |
| TSGLSSMGPEQVNDP | 1421 | Q15596 | |
| PGSEEKNQGPSMIGR | 2641 | A4UGR9 | |
| QPDGQMPSDKTIGGG | 31 | P0DPH8 | |
| MGQPGPSGDSDLATA | 471 | O60296 | |
| PQEQSTGDTMGRDPG | 246 | O95229 | |
| SQEEGTEGPQGMDPL | 351 | A0A0J9YY54 | |
| NSNKMSISPGVAGPG | 336 | Q9H171 | |
| SMPTAGSAGSVPENL | 231 | Q8WU79 | |
| GSPMGSRTGSETPQA | 476 | Q8WXF1 | |
| ATMGTENTPGGKASP | 21 | O94956 | |
| RQMSSSDGGPPGQSD | 381 | Q9NXL6 | |
| MSQAGDVEGPSTGDP | 1 | Q6ZMY3 | |
| MAESGESGGPPGSQD | 1 | Q9UMX0 | |
| QPDGQMPSDKTIGGG | 31 | P0DPH7 | |
| SGQPSPDQSGLDMTG | 171 | Q92753 | |
| PTGPNATESVQPMEG | 566 | Q9Y5S1 | |
| EQDGGTQNPVSSPGM | 356 | P46937 | |
| AVPTSRGMPGTVQSG | 551 | P78364 | |
| QVSDVPMTGNPAEEG | 381 | Q6ZSY5 | |
| RMGEPSQDPKQGTSG | 1376 | O95359 | |
| GPSSPQGEAMVTDVL | 1111 | Q12888 | |
| AGENVLPSTMQPGDD | 146 | Q6UWH6 | |
| QDGGLMQASVPGPSE | 641 | Q8NB14 | |
| TSMLVPGAGEPNFDG | 471 | O15213 | |
| VPSEPGIQPMGQDSG | 191 | Q9ULM0 | |
| QVMTSQGLVSPSGGP | 1476 | Q9UL36 | |
| QPDGQMPSDKTIGGG | 31 | Q71U36 | |
| PGTVQVSVNGMDDSP | 336 | Q8TD55 | |
| QPDGQMPSDKTIGGG | 31 | Q6PEY2 | |
| GPPEGEGSQDSNPMQ | 156 | O75800 | |
| ATENGTANGVPPMAT | 836 | Q2M1K9 | |
| QPDGQMPSDKTIGGG | 31 | P68363 | |
| SAPDIGSKGMNQVPG | 526 | A4D1P6 | |
| GPALPQEENTGEEGM | 11 | Q15937 | |
| QGGNLLEEQPMSPSG | 746 | Q702N8 | |
| GEQPMEGSHQGAPES | 1446 | Q702N8 | |
| QPDGQMPSDKTIGGG | 31 | Q9BQE3 | |
| SEGSMAQEGSPGRAP | 146 | Q8IV31 | |
| PSNREMPSEEGTLNG | 1526 | Q96QT4 | |
| GQPEMAPQSEPREGS | 16 | Q7Z7K2 | |
| QPDGQMPSDKTIGGG | 31 | P68366 | |
| NGPAQQSEGMAPVSS | 966 | Q9ULM3 | |
| EGRQGPGKQPMETTQ | 396 | Q86VY4 | |
| MDGSGERSLPEPGSQ | 1 | Q9H3M0 | |
| LPGTQDPGMSGLSQT | 2661 | O14686 |